1,116
Views
23
CrossRef citations to date
0
Altmetric
Original Research

Anti-proliferative and pro-apoptotic activity of GD2 ganglioside-specific monoclonal antibody 3F8 in human melanoma cells

, , , , , & show all
Article: e1023975 | Received 03 Feb 2015, Accepted 20 Feb 2015, Published online: 25 Jul 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

S. Faraj, M. Bahri, S. Fougeray, A. El Roz, J. Fleurence, J. Véziers, M. D. Leclair, E. Thébaud, F. Paris & S. Birklé. (2018) Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside. OncoImmunology 7:1.
Read now

Articles from other publishers (22)

Pierre Machy, Erwan Mortier & Stéphane Birklé. (2023) Biology of GD2 ganglioside: implications for cancer immunotherapy. Frontiers in Pharmacology 14.
Crossref
Cristina Larrosa, Jaume Mora & Nai-Kong Cheung. (2023) Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2. Cancers 15:14, pages 3729.
Crossref
Jung-Tung Hung & Alice L. Yu. 2023. Glycosignals in Cancer. Glycosignals in Cancer 215 238 .
Mohamad Bahij Moumneh, Tarek Bou Dargham, Marguerite Mrad & Ghassan Dbaibo. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology 1 39 .
Anastas PashovRamachandran MuraliIssam MakhoulBehjatolah KarbassiThomas Kieber-Emmons. (2022) Harnessing Antibody Polyspecificity for Cancer Immunotherapy. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy 41:5, pages 290-300.
Crossref
Johanna Theruvath, Marie Menard, Benjamin A. H. Smith, Miles H. Linde, Garry L. Coles, Guillermo Nicolas Dalton, Wei Wu, Louise Kiru, Alberto Delaidelli, Elena Sotillo, John L. Silberstein, Anna C. Geraghty, Allison Banuelos, Molly Thomas Radosevich, Shaurya Dhingra, Sabine Heitzeneder, Aidan Tousley, John Lattin, Peng Xu, Jing Huang, Nicole Nasholm, Andy He, Tracy C. Kuo, Emma R. B. Sangalang, Jaume Pons, Amira Barkal, Rachel E. Brewer, Kristopher D. Marjon, Jose G. Vilches-Moure, Payton L. Marshall, Ricardo Fernandes, Michelle Monje, Jennifer R. Cochran, Poul H. Sorensen, Heike E. Daldrup-Link, Irving L. Weissman, Julien Sage, Ravindra Majeti, Carolyn R. Bertozzi, William A. Weiss, Crystal L. Mackall & Robbie G. Majzner. (2022) Anti-GD2 synergizes with CD47 blockade to mediate tumor eradication. Nature Medicine 28:2, pages 333-344.
Crossref
Pouya Safarzadeh Kozani, Pooria Safarzadeh Kozani & Roddy S. O'Connor. (2021) In Like a Lamb; Out Like a Lion: Marching CAR T Cells Toward Enhanced Efficacy in B-ALL. Molecular Cancer Therapeutics 20:7, pages 1223-1233.
Crossref
Norihiko Sasaki, Masashi Toyoda & Toshiyuki Ishiwata. (2021) Gangliosides as Signaling Regulators in Cancer. International Journal of Molecular Sciences 22:10, pages 5076.
Crossref
Taranom Mobasheri, Elham Rayzan, Mahsima Shabani, Mina Hosseini, Ghanbar Mahmoodi Chalbatani & Nima Rezaei. (2020) Neuroblastoma‐targeted nanoparticles and novel nanotechnology‐based treatment methods. Journal of Cellular Physiology 236:3, pages 1751-1775.
Crossref
Suresh Madheswaran, Neelakshi Mungra, Fleury A.N. Biteghe, Jean De la Croix Ndong, Afolake T. Arowolo, Henry A. Adeola, Dharanidharan Ramamurthy, Krupa Naran, Nonhlanhla P. Khumalo & Stefan Barth. (2020) Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers. Anti-Cancer Agents in Medicinal Chemistry 21:2, pages 162-186.
Crossref
John Yu, Jung‐Tung Hung, Sheng‐Hung Wang, Jing‐Yan Cheng & Alice L. Yu. (2020) Targeting glycosphingolipids for cancer immunotherapy. FEBS Letters 594:22, pages 3602-3618.
Crossref
Lorry Carrié, Mathieu Virazels, Carine Dufau, Anne Montfort, Thierry Levade, Bruno Ségui & Nathalie Andrieu-Abadie. (2020) New Insights into the Role of Sphingolipid Metabolism in Melanoma. Cells 9:9, pages 1967.
Crossref
Bassel Nazha, Cengiz Inal & Taofeek K. Owonikoko. (2020) Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy. Frontiers in Oncology 10.
Crossref
Cinthia Violeta Hernandez Puente, Ping-Ching Hsu, Lora J. Rogers, Fariba Jousheghany, Eric Siegel, Susan A. Kadlubar, J. Thaddeus Beck, Issam Makhoul, Laura F. Hutchins, Thomas Kieber-Emmons & Behjatolah Monzavi-Karbassi. (2020) Association of DNA-Methylation Profiles With Immune Responses Elicited in Breast Cancer Patients Immunized With a Carbohydrate-Mimicking Peptide: A Pilot Study. Frontiers in Oncology 10.
Crossref
Anastas Pashov & Thomas Kieber-Emmons. 2019. Cancer Immunotherapy and Biological Cancer Treatments. Cancer Immunotherapy and Biological Cancer Treatments.
Roman V. Kholodenko, Daniel V. Kalinovsky, Igor I. Doronin, Eugene D. Ponomarev & Irina V. Kholodenko. (2019) Antibody Fragments as Potential Biopharmaceuticals for Cancer Therapy: Success and Limitations. Current Medicinal Chemistry 26:3, pages 396-426.
Crossref
Jung-Tung Hung & Alice L. Yu. 2019. Neuroblastoma. Neuroblastoma 63 78 .
Sophie Groux-Degroote, Macarena Rodríguez-Walker, Justine H. Dewald, Jose L. Daniotti & Philippe Delannoy. 2018. Gangliosides in Health and Disease. Gangliosides in Health and Disease 197 227 .
Laura F. Hutchins, Issam Makhoul, Peter D. Emanuel, Angela Pennisi, Eric R. Siegel, Fariba Jousheghany, Xueyan Guo, Anastas D. Pashov, Behjatolah Monzavi-Karbassi & Thomas Kieber-Emmons. (2017) Targeting tumor-associated carbohydrate antigens: a phase I study of a carbohydrate mimetic-peptide vaccine in stage IV breast cancer subjects. Oncotarget 8:58, pages 99161-99178.
Crossref
Julien Fleurence, Sophie Fougeray, Meriem Bahri, Denis Cochonneau, Béatrice Clémenceau, François Paris, Andras Heczey & Stéphane Birklé. (2017) Targeting O -Acetyl-GD2 Ganglioside for Cancer Immunotherapy . Journal of Immunology Research 2017, pages 1-16.
Crossref
Alice L. YuJung-Tung HungMing-Yi HoJohn Yu. (2016) Alterations of Glycosphingolipids in Embryonic Stem Cell Differentiation and Development of Glycan-Targeting Cancer Immunotherapy. Stem Cells and Development 25:20, pages 1532-1548.
Crossref
A. A. Zubareva, A. A. Boyko, I. V. Kholodenko, F. N. Rozov, M. V. Larina, T. K. Aliev, I. I. Doronin, P. A. Vishnyakova, I. M. Molotkovskaya & R. V. Kholodenko. (2016) Chitosan nanoparticles targeted to the tumor-associated ganglioside GD2. Russian Journal of Bioorganic Chemistry 42:5, pages 532-545.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.